Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay

Berkhout, LC; I'Ami, MJ; Ruwaard, J; Hart, MH; Ooijevaar-de Heer, P; Bloem, K; Nurmohamed, MT; van Vollenhoven, RF; Boers, M; Alvarez, DF; Smith, CH; Wolbink, GJ; Rispens, T

Rispens, T (reprint author), Sanquin Res, Dept Immunopathol, NL-1066 CX Amsterdam, Netherlands.; Rispens, T (reprint author), Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, Amsterdam, Netherlands.

SCIENCE TRANSLATIONAL MEDICINE, 2019; 11 (477):

Abstract

Patients with rheumatoid arthritis (RA) can be successfully treated with tumor necrosis factor (TNF) inhibitors, including the monoclonal antibody ada......

Full Text Link